Relative Value Partners Group, LLC Pfizer Inc Transaction History

Relative Value Partners Group, LLC

$751 Million
Q2 2024

A detailed history of Relative Value Partners Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Relative Value Partners Group, LLC holds 28,589 shares of PFE stock, worth $755,321. This represents 0.11% of its overall portfolio holdings.

Number of Shares

28,589

Previous 15,917 79.61%

Holding current value

$755,321

Previous $441,000 81.18%

% of portfolio

0.11%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$25.26 - $29.6 $320,094 - $375,091	12,672 Added 79.61%	28,589 $799,000
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $85,695 - $98,406	-3,310 Reduced 17.22%	15,917 $441,000
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $3,867 - $5,023	148 Added 0.78%	19,227 $553,000
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $184,645 - $215,832	5,754 Added 43.18%	19,079 $632,000
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $144 - $167	4 Added 0.03%	13,325 $488,000
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $63,929 - $83,227	-1,623 Reduced 10.86%	13,321 $543,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $119,196 - $155,597	2,855 Added 23.62%	14,944 $766,000
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $162,174 - $197,974	-3,706 Reduced 23.46%	12,089 $529,000
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $64,304 - $76,244	-1,382 Reduced 8.05%	15,795 $778,000
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $290,100 - $359,471	6,341 Added 58.52%	17,177 $889,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $17,662 - $22,689	450 Added 4.33%	10,836 $466,000
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $32,390 - $36,693	-902 Reduced 7.99%	10,386 $407,000
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $44,809 - $50,536	1,338 Added 13.45%	11,288 $409,000
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $35,143 - $44,688	-1,050 Reduced 9.55%	9,950 $366,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $120,650 - $141,550	3,800 Added 52.78%	11,000 $404,000
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $16,245 - $21,065	500 Added 7.46%	7,200 $245,000
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $33,208 - $37,284	-898 Reduced 11.82%	6,700 $290,000
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $52,425 - $57,597	1,398 Added 22.55%	7,598 $323,000
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $16,490 - $17,580	-500 Reduced 7.46%	6,200 $225,000
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $22,337 - $25,914	700 Added 11.67%	6,700 $238,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,000	6,000 $202,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Relative Value Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relative Value Partners Group, LLC with notifications on news.

Account

Relative Value Partners Group, LLC Pfizer Inc Transaction History